Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -23.00%-11.9M | ---- | 25.02%-9.68M | ---- | 69.31%-12.91M | ---- | 47.00%-42.06M | ---- | 24.55%-79.35M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 65.12%-120K | ---- | -2,357.14%-344K | ---- | 82.93%-14K | ---- | 76.77%-82K | ---- | -65.73%-353K |
| Investment loss (gain) | ---- | ---17.29M | ---- | ---- | ---- | ---6.72M | ---- | ---- | ---- | ---- |
| Impairment and provisions: | ---- | 7,521.91%13.21M | ---- | -166.17%-178K | ---- | -88.66%269K | ---- | -77.75%2.37M | ---- | 97.28%10.67M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.52M | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | -106.11%-540K | ---- | -415.66%-262K | ---- | --83K | ---- | ---- | ---- | ---74K |
| -Other impairments and provisions | ---- | 16,270.24%13.75M | ---- | -54.84%84K | ---- | -78.27%186K | ---- | -92.03%856K | ---- | 98.65%10.74M |
| Revaluation surplus: | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -20.57%-3.58M | ---- | -163.96%-2.97M |
| -Other fair value changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -20.57%-3.58M | ---- | -163.96%-2.97M |
| Asset sale loss (gain): | ---- | -1,043.42%-869K | ---- | 93.76%-76K | ---- | -168.65%-1.22M | ---- | -2,416.67%-453K | ---- | 98.12%-18K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -1,043.42%-869K | ---- | 93.76%-76K | ---- | -168.65%-1.22M | ---- | -2,416.67%-453K | ---- | 98.12%-18K |
| Depreciation and amortization: | ---- | -15.13%10.23M | ---- | 10.40%12.05M | ---- | -3.49%10.92M | ---- | -71.02%11.31M | ---- | -11.88%39.03M |
| -Amortization of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -0.28%18.32M |
| Financial expense | ---- | -54.84%5.42M | ---- | -8.99%12M | ---- | -35.92%13.18M | ---- | 120.88%20.57M | ---- | -67.31%9.31M |
| Exchange Loss (gain) | ---- | 70.00%-6K | ---- | -900.00%-20K | ---- | 33.33%-2K | ---- | -100.82%-3K | ---- | 165.12%364K |
| Special items | ---- | ---- | ---- | 478.48%1.37M | ---- | 347.17%237K | ---- | -88.25%53K | ---- | -94.31%451K |
| Operating profit before the change of operating capital | ---- | -108.80%-1.33M | ---- | 303.90%15.13M | ---- | 131.57%3.75M | ---- | 48.11%-11.86M | ---- | -41.10%-22.86M |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | -1.51%21.52M | ---- | 6,053.68%21.85M | ---- | 99.35%-367K | ---- | -456.10%-56.31M | ---- | 19.79%15.81M |
| Accounts payable increase (decrease) | ---- | -66.78%-28.09M | ---- | -292.12%-16.84M | ---- | -84.27%8.77M | ---- | 10,361.88%55.72M | ---- | -101.73%-543K |
| Special items for working capital changes | ---- | 145.79%6.93M | ---- | -362.84%-15.14M | ---- | 157.98%5.76M | ---- | -71,042.86%-9.93M | ---- | 101.63%14K |
| Cash from business operations | ---- | -119.35%-967K | ---- | -72.08%5M | ---- | 179.99%17.9M | ---- | -195.54%-22.38M | ---- | -127.56%-7.57M |
| Other taxs | ---- | 74.08%-106K | ---- | -113.29%-409K | ---- | 753.29%3.08M | ---- | -45.82%-471K | ---- | 70.58%-323K |
| Special items of business | -332.64%-11.97M | ---- | -19.60%5.14M | ---- | -76.55%6.4M | ---- | 215.34%27.29M | ---- | -46.02%-23.66M | ---- |
| Net cash from operations | -332.64%-11.97M | -123.38%-1.07M | -19.60%5.14M | -78.13%4.59M | -76.55%6.4M | 191.81%20.98M | 215.34%27.29M | -189.41%-22.85M | -46.02%-23.66M | -129.94%-7.9M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -65.12%120K | ---- | 2,357.14%344K | ---- | -82.93%14K | ---- | -76.77%82K | ---- | 65.73%353K |
| Sale of fixed assets | ---- | 74.95%922K | ---- | -69.71%527K | ---- | 87.30%1.74M | ---- | 378.87%929K | ---- | -86.43%194K |
| Purchase of fixed assets | 38.64%-5.11M | -151.81%-9.17M | -165.63%-8.33M | 44.73%-3.64M | 21.30%-3.13M | -1.09%-6.59M | 3.00%-3.98M | 43.54%-6.52M | -16.16%-4.11M | -54.43%-11.55M |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --8.38M | ---- | ---- |
| Other items in the investment business | -50.79%250K | ---- | 36.56%508K | ---- | -62.31%372K | ---- | -89.06%987K | ---- | 1,100.80%9.02M | ---- |
| Net cash from investment operations | 37.85%-4.86M | -193.36%-8.13M | -183.02%-7.82M | 42.69%-2.77M | 7.78%-2.76M | -268.58%-4.84M | -160.96%-3M | 126.08%2.87M | 276.54%4.91M | -127.70%-11M |
| Net cash before financing | -529.44%-16.83M | -606.16%-9.2M | -173.51%-2.67M | -88.74%1.82M | -85.03%3.64M | 180.79%16.15M | 229.60%24.29M | -5.77%-19.98M | 1.27%-18.74M | -187.69%-18.89M |
| Cash flow from financing activities | ||||||||||
| Issuing shares | ---- | --20M | --20M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Absorb investment income | --135K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items of the financing business | 65.82%-595K | ---- | 44.34%-1.74M | ---- | -27.00%-3.13M | ---- | 16.93%-2.46M | ---- | -14.39%-2.97M | --1.5M |
| Net cash from financing operations | -102.52%-460K | 398.69%17.09M | 683.73%18.26M | 18.79%-5.72M | -27.00%-3.13M | -64.69%-7.05M | 16.93%-2.46M | 30.67%-4.28M | -14.39%-2.97M | 37.22%-6.17M |
| Effect of rate | -88.89%2K | -98.82%6K | 350.00%18K | 1,402.56%508K | 122.22%4K | -148.75%-39K | -325.00%-18K | -86.95%80K | 108.16%8K | 240.92%613K |
| Net Cash | -210.90%-17.29M | 302.10%7.89M | 2,968.11%15.59M | -142.92%-3.91M | -97.67%508K | 137.50%9.1M | 200.55%21.83M | 3.20%-24.26M | -0.61%-21.71M | -313.95%-25.07M |
| Begining period cash | 16.38%56.12M | -6.58%48.22M | -6.58%48.22M | 21.29%51.62M | 21.29%51.62M | -36.23%42.56M | -36.23%42.56M | -26.81%66.74M | -26.81%66.74M | 14.12%91.2M |
| Cash at the end | -39.15%38.84M | 16.38%56.12M | 22.43%63.83M | -6.58%48.22M | -19.01%52.13M | 21.29%51.62M | 42.91%64.37M | -36.23%42.56M | -35.21%45.04M | -26.81%66.74M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Auditor | -- | National Health Accounting Firm Limited | -- | National Health Accounting Firm Limited | -- | National Health Accounting Firm Limited | -- | National Health Accounting Firm Limited | -- | National Health Accounting Firm Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.